Trends in androgen prescribing in the United States, 2001 to 2011. - Wikidata - awgldk - TriplyDB

Trends in androgen prescribing in the United States, 2001 to 2011.

Trends in androgen prescribing in the United States, 2001 to 2011.

http://www.wikidata.org/entity/Q33909321

about

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men Adverse effects of testosterone replacement therapy: an update on the evidence and controversy Testosterone therapy in the new era of Food and Drug Administration oversight A summary of the controversy surrounding off-label medications in men's health An update on the role of testosterone replacement therapy in the management of hypogonadism Testosterone Replacement Therapy and Cardiovascular Risk: A Review Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk Preserving fertility in the hypogonadal patient: an update Patient satisfaction with testosterone replacement therapies: the reasons behind the choices The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men A definition and ethical evaluation of overdiagnosis: response to commentaries.Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.2016 Update on Medical Overuse: A Systematic Review.Testosterone treatment is a potent tumor promoter for the rat prostate.Testosterone deficiency in adults and corresponding treatment patterns across the globe.A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor.Translational studies in older men using testosterone to treat sarcopenia.An update on male hypogonadism therapy.Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy.Testosterone deficiency and cardiovascular mortality.The utility and dynamics of salivary sex hormone measurements in the National Social Life, Health, and Aging Project, Wave 2 Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.The implications of low testosterone on mortality in men Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.Comparative Safety of Testosterone Dosage Forms.Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study.Changes in testosterone related to body composition in late midlife: Findings from the 1946 British birth cohort study Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency A Subset of Men With Age-Related Decline in Testosterone Have Gonadotroph Autoantibodies.Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant Testosterone therapy and prostate cancer.Off label therapies for testosterone replacement.A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients.Testosterone replacement in the infertile man.

P2860

Q21132351-7AAB7377-CB6A-44F2-9C54-954BEBFFC27C Q24564836-636E4767-C263-4955-99E7-5FCBA0E894F2 Q26747665-7798943E-8501-44F7-B79A-9AC8A60F1933 Q26747667-0F6867C8-172E-48A2-80AE-DCCBB9F5551A Q26749076-C0100471-7403-4424-B952-CF1B1E4DFCCD Q26771771-28F7B6C7-ABC3-4F3B-8861-F74522471299 Q26775766-7DE145EA-F06B-4AB5-ABFF-38B45F54ED87 Q27027785-73F95EDA-F94E-4981-B9DA-207A785E3FFE Q28304192-9019BF8D-C5C3-49D0-AEE4-30ED3FF96155 Q28540783-FF915FF9-F5FB-4BEA-8C68-7D86B5ACF975 Q30392356-5662C8CB-185A-4811-9677-E5E575D9E972 Q30587292-2A2AA1EC-0377-4FAE-A3D5-41A07B61DA01 Q31099075-F9D62E7D-1FEF-4D66-B201-A76DEC977487 Q33167715-49BB9282-E7B9-4DF4-B4AA-3CC1B47D4673 Q33569704-DFCFD601-F5A5-4458-9F21-9EE2F37A7D48 Q33650762-127D58BE-3B0F-456D-9289-94CC525EBAD2 Q33690473-2B354937-CFF4-4FB9-84B2-5CE095B8EC6E Q33890197-AC84D9CB-2787-4A0A-86F7-699CD28086B8 Q33890595-845FD0A7-D158-4B3A-B4BD-02E152204278 Q33957794-1CF7E625-4B40-46F9-AC1C-A95501436CFF Q34207540-924E47C1-6DB4-484E-BAF3-E18CF6656A57 Q34449460-712C58F6-4EFA-4AD2-98F1-E0A30DDCC6BD Q34807478-4D2985D1-5585-4B42-911B-DB7F5C5FECAE Q34927884-E32F1A6A-CC3B-4614-9C77-C35153A1F9C6 Q35000112-A7EB60CD-1B0B-42D1-8077-0220564AC994 Q35044878-79C9A681-42CE-4B32-AF1F-7DCBB0F8FA9C Q35068943-27105E92-3D5F-47F2-B37E-0CDC98CC08CF Q35233159-2F2B8BD0-B975-4F4F-AA38-221B88AD1993 Q35828716-5D5005ED-7EAE-4514-9ECE-E7FF5ADD0113 Q35847197-D7291FEC-3D3E-4AA3-9752-1585B8AEC5E2 Q36485518-11A03CCE-9669-442C-B92B-902833D96497 Q36554482-5D7C97CE-48BD-4DC4-9522-91C3419B5BE3 Q36861538-7F284D0F-79CA-49F3-8CF9-81D2DDC1CDAA Q36880263-F7D344FB-68A8-43D3-8937-C18E4FB48D54 Q36935508-7067A66B-E664-44D4-A5E8-117B904AAD2F Q37148246-64C5110B-EFDC-4A10-9C84-3EBF3B232C1F Q37531045-FB6A84FF-C487-4CFF-AF59-082D78B3D4B4 Q37531056-B15A9A32-ECD7-4CFC-A189-AFB28299D9B4 Q37531062-71C149B1-18C4-4792-9DE5-9F8F8D9CDFC3 Q37531072-A94AAC31-245D-4D97-A551-18AB83E158C8

P2860

Trends in androgen prescribing in the United States, 2001 to 2011.

http://www.wikidata.org/entity/Q33909321

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Trends in androgen prescribing in the United States, 2001 to 2011.

@ast

Trends in androgen prescribing in the United States, 2001 to 2011.

@en

type

label

Trends in androgen prescribing in the United States, 2001 to 2011.

@ast

Trends in androgen prescribing in the United States, 2001 to 2011.

@en

prefLabel

Trends in androgen prescribing in the United States, 2001 to 2011.

@ast

Trends in androgen prescribing in the United States, 2001 to 2011.

@en

P1433

Q33909321-F5A9D794-40C7-4BD2-BF69-DF61028828FF

P1476

Q33909321-3295588D-AB4A-47BF-9847-9159F5826D59

P2093

Q33909321-4A8BF766-2283-4E9D-905C-C14D373E98B4

Q33909321-6EFA6053-EFD6-4D8F-9FD1-61FD9A34EE8A

Q33909321-862E3E54-F850-4B05-AF82-132097947E51

Q33909321-A1D0B5F2-9F6D-4BC8-947F-F950048C5BBE

P2860

Q33909321-0A345748-3176-4008-A7E5-9CF1234E001F

Q33909321-20F64981-2509-400D-A978-35D7B2C612CA

Q33909321-7F1AF50C-8596-4F38-8238-66999CF875BA

Q33909321-9328C116-F4E5-4805-80AE-C98786F68727

Q33909321-C716AD6F-57FB-46CC-B870-C88BE28B5555

Q33909321-F2205BBC-6023-48D6-AA12-0F546F4D75CF

P304

Q33909321-36FC9FBF-EEF9-461A-8EE4-1D329EFAB8AB

P31

Q33909321-4B4C9765-4518-4E23-B58E-30300A72711C

P356

Q33909321-D5818FF3-4FC9-459A-83D8-6927D8878A60

P433

Q33909321-2464A896-4E76-4DFD-90F4-5927BF1BE244

P478

Q33909321-969BCB7E-98E0-4310-8B36-2CFB2C256679

P50

Q33909321-3A5D8F16-9740-4994-8ABC-692268BA87F5

P577

Q33909321-B609F687-EBA5-47C2-B14E-E95B1BE6D2B9

P5875

Q33909321-C7717CFE-2FE1-4A02-9431-824B0B68D05B

P698

Q33909321-4A27AB9C-6931-4904-B82E-9A736D5D426A

P921

Q33909321-C5D97A7D-C2A7-4503-81AA-21004B1FBE6E

P932

Q33909321-B85CCAF6-6E55-4D2E-8E66-1E7925D71A6A

P356

JAMAINTERNMED.2013.6895

P1433

JAMA Internal Medicine

P1476

Trends in androgen prescribing in the United States, 2001 to 2011

@en

P2093

Jacques Baillargeon

http://www.w3.org/2001/XMLSchema#string

James S Goodwin

http://www.w3.org/2001/XMLSchema#string

Karen S Pierson

http://www.w3.org/2001/XMLSchema#string

Randall J Urban

http://www.w3.org/2001/XMLSchema#string

P2860

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

Adverse events associated with testosterone administration

Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

P304

1465-1466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAINTERNMED.2013.6895

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth J. Ottenbacher

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255790065

http://www.w3.org/2001/XMLSchema#string

P698

23939517

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

4100547

http://www.w3.org/2001/XMLSchema#string